{"version":"1.0","provider_name":"Taiwan Newswire","provider_url":"https:\/\/taiwannewswire.com","author_name":"admin","author_url":"https:\/\/taiwannewswire.com\/author\/admin\/","title":"Patients Rate their Clinical Trial Experience Positively,\u00a0but Trial Locations Still Pose Barriers to Enrollment - Taiwan Newswire","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"1zxUznhJMB\"><a href=\"https:\/\/taiwannewswire.com\/patients-rate-their-clinical-trial-experience-positively-but-trial-locations-still-pose-barriers-to-enrollment\/\">Patients Rate their Clinical Trial Experience Positively,\u00a0but Trial Locations Still Pose Barriers to Enrollment<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/taiwannewswire.com\/patients-rate-their-clinical-trial-experience-positively-but-trial-locations-still-pose-barriers-to-enrollment\/embed\/#?secret=1zxUznhJMB\" width=\"600\" height=\"338\" title=\"&#8220;Patients Rate their Clinical Trial Experience Positively,\u00a0but Trial Locations Still Pose Barriers to Enrollment&#8221; &#8212; Taiwan Newswire\" data-secret=\"1zxUznhJMB\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n<\/script>\n","description":"New Informa Pharma Intelligence survey uncovers patient sentiment\u00a0on clinical trial participation NEW YORK, July 27, 2021 (GLOBE NEWSWIRE) \u2014\u00a0Informa Pharma Intelligence, the global business intelligence provider for the biopharma industry, released its first \u201cPatient Perspectives on Clinical Trial Participation\u201d report, which measured patient attitudes in relation to all stages of the clinical trial process following [\u2026]"}